Gautam Sethi Selected Research

Protein Kinases (Protein Kinase)

11/2019	Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements.
2/2015	The multifaceted role of curcumin in cancer prevention and treatment.
10/2014	β-Caryophyllene oxide inhibits constitutive and inducible STAT3 signaling pathway through induction of the SHP-1 protein tyrosine phosphatase.
5/2012	Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
5/2007	Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gautam Sethi Research Topics

Disease

321	Neoplasms (Cancer) 05/2024 - 11/2005
80	Neoplasm Metastasis (Metastasis) 02/2024 - 07/2006
48	Carcinogenesis 01/2023 - 06/2006
40	Breast Neoplasms (Breast Cancer) 12/2023 - 04/2007
39	Inflammation (Inflammations) 05/2024 - 02/2006
35	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 06/2010
27	Multiple Myeloma 01/2022 - 03/2007
16	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 04/2007
13	Lung Neoplasms (Lung Cancer) 09/2023 - 04/2007
12	Chronic Disease (Chronic Diseases) 01/2022 - 06/2007
10	Stomach Neoplasms (Stomach Cancer) 09/2023 - 09/2011
10	Carcinoma (Carcinomatosis) 04/2019 - 04/2007
8	Squamous Cell Carcinoma of Head and Neck 10/2023 - 08/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2007
7	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 11/2005
7	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 09/2006
6	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 01/2016
6	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 05/2015
6	Mouth Neoplasms (Oral Cancer) 10/2023 - 06/2007
6	Hypoxia (Hypoxemia) 01/2023 - 02/2012
6	Body Weight (Weight, Body) 01/2022 - 01/2012
6	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2016
6	Leukemia 01/2021 - 03/2006
5	Triple Negative Breast Neoplasms 04/2024 - 03/2016
5	Adenocarcinoma 02/2024 - 10/2011
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2023 - 02/2015
5	Arthritis (Polyarthritis) 08/2019 - 11/2005
5	Asthma (Bronchial Asthma) 08/2019 - 04/2011
4	Liver Neoplasms (Liver Cancer) 02/2023 - 11/2010
4	Melanoma (Melanoma, Malignant) 02/2022 - 06/2007
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2014
4	Necrosis 01/2021 - 06/2007

Drug/Important Bio-Agent (IBA)

54	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2007
49	Transcription Factors (Transcription Factor)IBA 02/2024 - 03/2006
43	NF-kappa B (NF-kB)IBA 12/2023 - 02/2006
36	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2023 - 05/2007
20	CytokinesIBA 05/2024 - 02/2006
20	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2014
17	Phosphotransferases (Kinase)IBA 01/2023 - 09/2006
17	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2014
16	PhytochemicalsIBA 04/2024 - 11/2012
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2024 - 03/2006
14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 02/2006
13	EnzymesIBA 01/2024 - 06/2007
13	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 02/2006
12	CateninsIBA 02/2024 - 01/2017
12	AntioxidantsIBA 01/2023 - 01/2011
11	CurcuminIBA 05/2024 - 11/2005
11	LigandsIBA 01/2024 - 11/2010
11	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2012
11	TriterpenesIBA 06/2019 - 03/2006
10	Therapeutic UsesIBA 01/2024 - 11/2012
10	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 02/2012
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2011
10	Cyclin D1IBA 03/2015 - 02/2006
9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 02/2006
9	Bortezomib (Velcade)FDA Link 12/2019 - 05/2007
9	SurvivinIBA 10/2015 - 02/2006
8	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 10/2012
8	ResveratrolIBA 01/2024 - 03/2007
8	celastrolIBA 09/2021 - 04/2007
8	thymoquinoneIBA 01/2018 - 07/2008
7	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2024 - 01/2022
7	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 06/2007
7	TocotrienolsIBA 02/2024 - 05/2011
7	LipidsIBA 01/2024 - 12/2017
7	AlkaloidsIBA 12/2023 - 07/2008
7	CarcinogensIBA 01/2023 - 11/2006
7	Mitogen-Activated Protein KinasesIBA 01/2021 - 02/2007
7	Ursolic AcidIBA 10/2016 - 09/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 02/2007
6	Circular RNAIBA 01/2023 - 01/2020
6	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2019 - 02/2012
5	Estrogen ReceptorsIBA 09/2023 - 04/2015
5	QuercetinIBA 02/2023 - 01/2012
5	Ligases (Synthetase)IBA 10/2022 - 01/2018
5	Insulin (Novolin)FDA Link 07/2022 - 11/2014
5	Neuroprotective AgentsIBA 01/2022 - 02/2017
5	TOR Serine-Threonine KinasesIBA 01/2022 - 05/2014
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2012
5	Cadherins (E-Cadherin)IBA 11/2020 - 12/2016
5	Protein Kinases (Protein Kinase)IBA 11/2019 - 05/2007
5	buteinIBA 02/2017 - 06/2007
5	Emodin (Archin)IBA 01/2017 - 01/2013
4	Peptides (Polypeptides)IBA 04/2024 - 04/2015
4	ChromatinIBA 11/2023 - 09/2011
4	FlavonoidsIBA 04/2023 - 12/2017
4	Long Noncoding RNAIBA 01/2023 - 12/2017
4	PolyphenolsIBA 01/2023 - 06/2007
4	InterleukinsIBA 01/2023 - 03/2006
4	ChemokinesIBA 08/2022 - 02/2006
4	Oncogene Proteins (Oncogene Protein)IBA 08/2022 - 01/2018
4	Histone Deacetylase InhibitorsIBA 09/2021 - 10/2016
4	DiosgeninIBA 09/2021 - 06/2010
4	bergamottinIBA 03/2021 - 11/2014

Therapy/Procedure

134	Therapeutics 04/2024 - 09/2006
33	Drug Therapy (Chemotherapy) 04/2024 - 03/2007
12	Immunotherapy 05/2024 - 10/2019
11	Radiotherapy 01/2024 - 11/2007
5	Precision Medicine 04/2024 - 11/2015